MetLife Investment Management’s Zogenix, Inc. ZGNX Stock Holding History

MetLife Investment Management’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,868	Closed	-$404K	–	2811
2021 Q4	$404K	Hold	24,868	–	–	﹤0.01%	1624
2021 Q3	$378K	Hold	24,868	–	–	﹤0.01%	1698
2021 Q2	$430K	Hold	24,868	–	–	﹤0.01%	1659
2021 Q1	$485K	Hold	24,868	–	–	﹤0.01%	1540
2020 Q4	$497K	Hold	24,868	–	–	﹤0.01%	1498
2020 Q3	$446K	Hold	24,868	–	–	﹤0.01%	1425
2020 Q2	$672K	Buy	24,868 +5,454	+28%	+$150K	0.01%	1219
2020 Q1	$480K	Hold	19,414	–	–	0.01%	1242
2019 Q4	$1.01M	Hold	19,414	–	–	0.01%	1097
2019 Q3	$777K	Hold	19,414	–	–	0.01%	1181
2019 Q2	$928K	Hold	19,414	–	–	0.01%	1139
2019 Q1	$1.07M	Hold	19,414	–	–	0.01%	1050
2018 Q4	$708K	Hold	19,414	–	–	0.01%	1170
2018 Q3	$963K	Buy	19,414 +2,693	+16%	+$137K	0.01%	1141
2018 Q2	$739K	Hold	16,721	–	–	0.01%	1174
2018 Q1	$670K	Hold	16,721	–	–	0.01%	1202
2017 Q4	$670K	Buy	+16,721	New	+$642K	0.01%	1233

MetLife Investment Management's ZGNX Position: Q1 2022 in Review

MetLife Investment Management sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 24,868 shares — an estimated $404K sold.

MetLife Investment Management first reported a position in ZGNX in Q4 2017 and held it in 17 quarters. The position peaked at $1.07M in Q1 2019. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

MetLife Investment Management reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
MetLife Investment Management sold 24,868 Zogenix, Inc. shares in Q1 2022, an estimated $404K.
MetLife Investment Management first reported a position in Zogenix, Inc. in Q4 2017 and held it in 17 quarters.
MetLife Investment Management's Zogenix, Inc. position peaked at $1.07M in Q1 2019.
0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.